Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
JOP. 2008 Jan 8;9(1):19-25.

Results following surgical resection for malignant pancreatic neuroendocrine tumours. A single institutional experience.

Author information

  • 1Department of HPB and Transplantation, The Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.

Abstract

OBJECTIVE:

The aim of the study was to present clinical outcomes of patients with malignant pancreatic neuroendocrine tumours (NET) following surgical resection with curative intent. Clinical and pathological factors that influenced the outcomes were also analysed.

DESIGN:

Retrospective case note study.

PATIENTS:

All patients with pancreatic NET that underwent surgery over a 7-year period (1999-2006).

RESULTS:

Twelve patients were identified with a median age at diagnosis of 54 years (range: 24-79 years). Common presenting symptoms include abdominal pain (n=8) and weight loss (n=3). Overall morbidity was 25% with one post-operative death. The median follow-up period was 41 months (range: 9-156 months). The overall 2- and 5-year actuarial survival rates were 88% and 70%, respectively. The overall survival was better in patients treated with surgery compared to patients managed medically (P<0.001). The disease-free survival rates were 62% at 2 and 5 years, respectively. Recurrent disease occurred in four patients and the median disease-free interval was 6 months (range: 3-14 months). On univariate analysis, angio-invasion (P=0.015) and degree of differentiation (P=0.024) were associated with developing recurrent disease.

CONCLUSION:

Surgical resection of malignant pancreatic NET results in good long-term survival in selected patients.

PMID:
18182738
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for JOP. Journal of the Pancreas (Online)
    Loading ...
    Write to the Help Desk